Payment to gamete donors: equality, gender equity, or solidarity? by Samorinha, Ana Catarina Carvalho et al.
ASSISTED REPRODUCTION TECHNOLOGIES
Payment to gamete donors: equality, gender equity, or solidarity?
C. Samorinha1 & C. De Freitas1,2,3 & I. Baía1,2 & H. Machado4 & E. Vale-Fernandes5 & S. Silva1,2
Received: 28 July 2019 /Accepted: 1 November 2019
# Springer Science+Business Media, LLC, part of Springer Nature 2019
Abstract
Purpose Regulation of payment to gamete donors varies substantially across countries. The development of an ethically sus-
tainable governance system of payments in gamete donation demands that the preferences of different stakeholders be heard. This
study intends to contribute to improving the understanding of payment to gamete donors by analysing the views of donors and
recipients about the preferred form of payment and its associations with their sociodemographic characteristics.
Methods This cross-sectional study included 70 donors and 172 recipients recruited at the Portuguese Public Bank of Gametes
(July 2017–June 2018). Participants completed a self-reported questionnaire. Views about the preferred form of payment were
collected through a multiple-choice question and an open-ended item. Associations were quantified through χ2 tests; content
analysis was conducted with the open-ended answers.
Results Both donors (48.6%) and recipients (40.7%) considered that reimbursement is the preferred form of payment to ensure
solidarity-based motivations to donate. This option was followed by compensation for non-financial losses (41.4% of donors;
33.7% of recipients) based on gender equity. Preference for a fixed reward (22.7% of recipients; 8.6% of donors) was less frequent
among younger donors and married/living with a partner or employed recipients, being based on the promotion of equality.
Conclusion In the context of the search for cross-border reproductive care and gamete circulation across countries, the findings
from this study claim for the need to create solutions for payment to gamete donors that take into account gender equity and are
simultaneously sensitive to donor’s actual expenses and further health complications.
Keywords Donor conception . Compensation . Reproductive techniques, assisted . Infertility
Introduction
Payment to gamete donors can be defined as a “generic term
covering all kinds of transactions involving money, and goods
with monetary value, whether those transactions are under-
stood as recompense, reward or purchases” (pp. 2) [1]. A
‘recompense’ occurs whenever a payment is made to donors
in recognition of material or other losses they have incurred (it
takes the form of ‘reimbursement’ in the case of payment of
direct financial losses or ‘compensation’ in the case of non-
financial losses, such as discomfort and time). A reward con-
sists in a material advantage gained by a person as a result of
donating gametes, which goes beyond a ‘recompense’ for the
losses they have incurred in the donation process. Lastly, pay-
ment can take the form of purchase if there is a direct ex-
change for the material being donated [1]. Nevertheless, the
need to establish strict limits for payment is widely recognized
to avoid the commercialization of human reproductive cells
[1–4], the exploitation of donors [3, 5, 6] and the concealment
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of relevant health information to be accepted as a donor [2, 7],
while ensuring solidarity-based motivations to donate, such as
helping a childless couple [4, 8–10]. The non-differentiation
of payment according to donors’ characteristics or the number
and quality of gametes has also reached a consensus, aiming
to avoid ‘positive eugenics’ and the commodification of bodi-
ly material [3, 11].
The conditions and regulation for payment to gamete do-
nors vary substantially across countries, being largely deter-
mined by ethical and social frameworks linked to donor-
assisted reproduction that are context-bound and value-laden
[12, 13]. The system of payment defined by a country may
influence, on the one side, the efficacy of donor recruitment
and the increase (or decrease) in the number of treatments [11]
and, on the other side, it may have an effect on the search for
cross-border reproductive care or shape the way gamete cir-
culation occurs across countries [14]. According to the reports
published by the European Commission [15] and the
International Federation of Fertility Societies [16], 68 coun-
tries have standardized data on national policies or guidelines
regarding payment to gamete donors. In over one-third (n =
28), both oocyte and sperm donors are reimbursed for time
and expenses, 16 provide compensation beyond reimburse-
ment (i.e. donors are entitled to receive, for example, small
tokens or a free physical check-up, beyond reimbursement for
time and expenses), seven do not provide any payment, six do
not have legislation in this field and four do not allow gamete
donation. In the remaining seven countries, recompense is
different for oocyte and sperm donors (in three of these coun-
tries, women have compensation beyond reimbursement
while men receive reimbursement for time and expenses).
The present study was conducted in Portugal, where donors
are recompensed both for loss of earnings (reimbursement)
and for inconvenience (compensation) through a fixed sum
of money, which has been recently updated to a maximum
of 843€ for oocyte donation and 338€ for sperm donation.
These values are set by the Government for all fertility clinics
in relation to the social support index (a monetary amount that
serves as a reference to the Portuguese Social Security for the
calculation of workers’ contributions, pensions and other so-
cial benefits): one-tenth of the index value for each sperm
donation and twice the value of the index for oocyte donation
[17]. In addition, donors are exempted from the payment of
user charges under the National Health Service [18] (e.g. users
do not need to pay for regular appointments with their family
physician). The National Health Service covers up to three
treatment cycles for recipients and 69% of the total cost of
infertility medication [19].
Literature has shown that payment of travel, time off work
and medical costs is seen as a fair option by donors [6, 20] and
recipients [21], as well as compensation for the invasive na-
ture of the procedures in oocyte donation and its associated
risks [2, 21]. Others have stated that offering gynaecological
check-ups [22] or free cinema tickets [21] beyond reimburse-
ment could be appropriate, arguing that it would improve the
availability of donated gametes [7, 21, 22]. Given the diversity
of perspectives about what should be considered an ethically
justifiable reward, as well as a reasonable and fair payment for
effort, time, inconvenience and discomfort associated with the
donation process [3, 5, 23], gathering data about the values
and preferences of the various stakeholders who are directly
involved in gamete donation is essential to guide policy con-
cerned with payment to gamete donors. However, data on
such topic is scarce. The very few studies analysing the influ-
ence of sociodemographic factors on the attitudes toward pay-
ment to gamete donors found no association between these
attitudes and gender, educational level, religion, age, income,
ethnicity, marital status, sexual orientation, occupation and
having biological children [7, 22, 24, 25]. Besides that, studies
have mainly focused on only one group of stakeholders at a
time: oocyte donors [20], sperm donors [8], gamete recipients
[21, 24] or the general public [7, 22]. Thus, empirical research
on the perspectives of donors and recipients about payment of
gamete donors and the respective associated factors is needed.
This study intends to contribute to improving the under-
standing about the payment to gamete donors by analysing the
views of oocyte and sperm donors as well as recipients about
the preferred form of payment and its associations with the
sociodemographic characteristics of the participants.
Materials and methods
Participants and data collection
In this observational cross-sectional study, gamete donors and
recipients who attended at least one medical appointment at the
Portuguese Public Bank of Gametes were invited to participate
between July 2017 and June 2018, regardless of the stage of the
treatment. This centre is located in a public hospital and per-
forms homologous and heterologous treatment cycles through
artificial insemination (AI) and in vitro fertilization (IVF)/
intracytoplasmic sperm injection (ICSI). At the end of the ap-
pointment, donors and recipients received an informative leaf-
let about the study from a health professional, after which all of
them were invited by a researcher to participate in the study,
who answered their questions. Those who decided to partici-
pate were accompanied to a private setting at the hospital,
where they read and signed the informed consent, developed
in accordance with the World Medical Association’s
Declaration of Helsinki and the Oviedo Convention, and com-
pleted a self-reported structured questionnaire. Of the 329 peo-
ple invited, 78 refused to participate in the study due to lack of
time (n = 39), unwillingness to participate (n = 20) and psycho-
logical unavailability (n = 8); others did not report the reason
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for refusal (n = 11). In total, 251 people (72 donors and 179
recipients) agreed to participate (response rate: 76.3%).
The structured questionnaire was purposely developed by
the research team for a wider project, concerning the ethical,
legal and social issues involved in gamete donation, based on
a literature review and a complete inventory of existing instru-
ments on the topic. The questionnaire was validated by ex-
perts from the social and health sciences and by a pilot admin-
istration to donors and recipients. This process resulted in
linguistic modifications, and some items were removed. The
final version of the questionnaire included 58 multiple-choice
items, one scale composed of 11 items and 12 open-ended
items divided into four sections: (1) opinions about access to
and governance of gamete donation (e.g. awareness of com-
munication campaigns, views about preferred forms of pay-
ment to donors and anonymity); (2) willingness to donate
gametes for family, friends and research purposes, as well as
to receive gametes from family, friends or unknown donors;
(3) willingness to donate embryos for reproductive and re-
search purposes; and (4) sociodemographic and reproductive
characteristics. Filling in the questionnaire required 15 min on
average. For the purposes of this paper, we analysed only the
results regarding the views about the preferred form of pay-
ment to gamete donors and their association with
sociodemographic data.
Views about the preferred form of payment to gamete
donors were measured through two items. First, a multiple-
choice question was presented: ‘There are different ways to
pay people who donate oocytes and sperm. In your opinion,
which of the following proposals is the most appropriate to
pay gamete donors? Please choose only one option’. The
response categories were the following: (1) A fixed amount
of money that is the same for all oocyte and sperm donors;
(2) A variable amount of money according to the type of
gametes donated—oocytes/sperm; (3) A variable amount of
money according to the donor’s actual expenses or losses
resulting from the donation; and (4) A variable amount of
money according to the characteristics of the donor. These
categories correspond to the synthesized terminology to de-
fine the payments made in connection with bodily material
proposed by the Nuffield Council on Bioethics [1], which
will be adopted in this manuscript: (1) A fixed amount of
money that is the same for all oocyte and sperm donors
corresponds to a ‘fixed reward’; (2) A variable amount of
money according to the type of gametes donated—oocytes/
sperm corresponds to ‘compensation’; (3) A variable amount
of money according to the donor’s actual expenses or losses
resulting from the donation corresponds to ‘reimbursement’;
and (4) A variable amount of money according to the char-
acteristics of the donor corresponds to ‘purchase’. Second,
participants answered the following open-ended question: ‘It
is important for us to understand the reason(s) for your an-
swer above. Please give a brief explanation’.
Data on the following sociodemographic characteristics
was analysed: sex, experience with gamete donation, educa-
tional level, marital status and working status. Educational
level was assessed through a multiple-choice item with the
following answer categories: (1) None, and cannot read or
write; (2) None, but can read and write; (3) 1st cycle of basic
education (4th year); (4) 2nd cycle of basic education (6th
grade); (5) 3rd cycle of basic education (9th grade); (6)
Secondary education (12th grade); (7) Bachelor’s degree; (8)
Licentiate degree; (9) Master’s/Integrated Master’s; and (10)
PhD. For analysis, this variable was dichotomized in ≤
Secondary education (12th grade) and > Secondary education
(12th grade). Perceived income adequacy was assessed
through the question: ‘Thinking of your household income,
would you say that your household is able to make ends
meet?’, being the answers categorized in three options:
insufficient/caution with expenses; enough to make ends
meet; and comfortable. Subjective social class was assessed
by asking participants to include themselves in one of the
following social classes: low, middle-low, middle-high, high
or none of the above. This study included 242 participants
with available data on the outcome: 70 gamete donors and
172 recipients. From these, 187 answered the open-ended
question (65 gamete donors and 122 recipients).
Data analysis
Descriptive data on the opinion about the preferred form of
payment to gamete donors according to participants’ charac-
teristics (categorical variables) is presented as counts and pro-
portions; medians and percentiles are presented for the contin-
uous variable ‘age’. The associations between the categorical
sociodemographic characteristics of participants and the out-
come were quantified through a chi-squared test or Fisher’s
exact test, in the cases that did not meet the chi-squared test
assumption that all expected frequencies in each cell should be
greater than five [26]. A post hoc test, with Bonferroni correc-
tion, was used to compare pairwise proportions. The outcome
response category ‘A variable amount of money according to
the characteristics of the donor’ (purchase) was not included
in this analysis due to the small number of individuals in each
category of the sociodemographic characteristics, which could
threaten the assurance of anonymity and confidentiality of
participants. The significance of the median differences for
the variable ‘age’ was calculated through the Kruskal–Wallis
test due to the non-parametric distribution of data in this var-
iable. The analyses were performed with the IBM Statistical
Package for the Social Sciences (SPSS) Statistics for
Windows, version 23.0, Armonk, NY, USA, and statistical
significance was defined as p < 0.05.
The contents of the answers to the open-ended question
with similar meanings were inductively synthesized into cat-
egories after emergent coding (i.e. categories were established
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following examination of the data), according to Stemler’s
protocol for content analysis [27]. This protocol was chosen
taking into account that we intended to determine the frequen-
cies of categories. The first and last authors independently
conducted coding, and disagreements in classification were
resolved by consensus. An almost perfect strength of agree-
ment between authors was achieved (≥ 0.81) [27]. The reasons
underlying participants’ opinion on the preferred form of pay-
ment to gamete donors were synthesized in the following cat-
egories: (1) ‘ensuring solidarity-based motivations’, which in-
cluded references to providing only a symbolic recompense to
a person for donating, taking into account an altruistic dimen-
sion of donation and the willingness to accept costs to assist
others based on the perception of similarity and shared social
practices and values; (2) ‘gender equity’, when quotations
advocated for different compensation values for women and
men, in order to enhance fairness; (3) ‘equality’, where the
answers established no difference between each of the parties
involved nor the type of reproductive cells, describing a sense
of similarity (among male and female donors, outcomes of
sperm/egg donation and analogies with donation of other bi-
ological material); (4) ‘encouraging more people to become
donors’; and (5) ‘financial gain’, containing arguments related
with receiving a material advantage. Participants’ answers
were classified in more than one category, when they provided
more than one reason underlying their opinion.
Ethical approval
Ethical approval was granted by the Portuguese Data Protection
Authority and the Ethics Committee for Health from the Centro
Hospitalar Universitário do Porto. All research data collected,
stored, processed and analysed have been anonymized. To guar-




Most participants were female (64.3% among donors and
61.0% among recipients), employed (55.1% of donors and
91.8% of recipients), perceived their subjective social class
as low/middle-low (72.6% of donors and 71.1% of recipients)
and their income as enough to make ends meet or comfortable
(70.0% among donors and 70.6% among recipients) (Table 1).
While 55.7% of donors had more than secondary education
(12th grade) and 82.9% were single/divorced, most recipients
had less than or equal to secondary education (12th grade)
(58.1%) and were married or living with a partner (90.1%).
The median age was lower among donors than recipients (me-
dian [P25-P75] = 26.0 [23.8–30.0] versus 36.0 [34.0–39.0]).
The opinion of oocyte and sperm donors
and recipients about payment to gamete donors
According to both donors and recipients, reimbursement is the
preferred form of payment to gamete donors (48.6% of donors
and 40.7% of recipients) (Table 1). This option was closely
followed by the preference for compensation (41.4% of do-
nors and 33.7% of recipients). Fewer participants considered
that a fixed reward should be provided to oocyte and sperm
donors, a more common position among recipients (22.7%)
than among donors (8.6%). Only a minority agreed with pur-
chasing (1.4% of donors and 2.9% of recipients).
Table 2 shows the associations between the sociodemographic
characteristics of the participants and their opinion about the pre-
ferred form of payment, stratified by donors and recipients.
Among donors, those who preferred the option of a fixed reward
were older (median [P25-P75] = 31.5 [28.5–37.0]) than those
who preferred compensation (median [P25-P75] = 27.0 [24.0–
29.5]) or reimbursement (median [P25-P75] = 25.0 [23.0–29.0]
p = 0.016). Among recipients, those who were married/living
with a partner were less likely to prefer the option of a fixed
reward (p = 0.043), as well as employed participants (p= 0.012).
Reasons underlying participants’ opinion on payment
to gamete donors
Participants, both donors and recipients, who considered that
the preferred form of payment to gamete donors should con-
sist in reimbursement justified their opinion mainly with rea-
sons related to ensuring solidarity-based motivations underly-
ing donation (26/30 donors and 33/54 recipients), which in-
cluded references to avoiding commercialization, commodifi-
cation and donors’ exploitation (Table 3). This view was com-
patible with giving recompense to a person for donating (to
cover expenses related with the donation, such as medication,
travelling, time and loss of earnings).
Most donors and recipients who selected compensation
justified their preference based on issues linked with gender
equity (24/29 donors and 30/45 recipients), acknowledging
the higher burden of oocyte donation compared with sperm
donation. The former is a more invasive and lengthy proce-
dure, causing pain and involving higher health risks for wom-
en who undergo the entire donation process. Gender equity
was referred to a lesser extent by recipients who opted for
reimbursement (14/54) and was never addressed by those (do-
nor or recipient) who defended a fixed reward.
The promotion of equality emerged as a key explanation
for preferring a fixed reward that is similar for oocyte and
sperm donors among recipients (17/23) and donors (5/6),
based on the view that the donations made bymen and women
are equal and have the same value, because both serve the
same objectives and are a means to help other people to
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conceive. This argument was never used by those who select-
ed compensation.
Regardless of the opinion about the preferred form of pay-
ment to gamete donors, fewer participants mentioned the need
to encourage more people to become donors or financial gain
as reasons to support their position.
Discussion
This study provides further information about donors’ and recip-
ients’ understanding of the preferred form of payment to gamete
donors by exploring the different representations and reasoning
underpinning the opinions of both groups of stakeholders in
Portugal. The results indicate a socioethical framework linked
to solidarity in combination with the values of equity or equality
and social representations of gender, where donors and recipients
seem to understand that there is more involved in payment to
gamete donors than either the difference between male and fe-
male gamete donation or the sense that only solidarity drives the
donors. Thus, data from this study holds potential to launch the
debate on the creation of payment solutions that integrate empir-
ical social scientific analysis about the real concerns of the stake-
holders [3, 28, 29] with an ethical analysis drawing normative
conclusions [30]. The fact that both donors and recipients would
prefer payment to consist of a variable amount of money depen-
dent on the donor’s actual expenses with or losses resulting from
the donation (reimbursement or compensation) and taking into
account the type of gametes donated, challenges the existence of
a predefined value system that is currently in force in 13 countries
Table 1 Characterization of the
participants, stratified by donors
and recipients
Total N = 242 Donors n = 70 Recipients n = 172
Age, median (P25-P75) 35.0 (29.0–38.0) 26.0 (23.8–30.0) 36.0 (34.0–39.0)
n (%) n (%) n (%)
Sex
Female 150 (62.0) 45 (64.3) 105 (61.0)
Male 92 (38.0) 25 (35.7) 67 (39.0)
Educational level
≤ Secondary education (12th grade) 128 (52.9) 31 (44.3) 97 (58.1)†
> Secondary education (12th grade) 109 (47.1) 39 (55.7) 70 (41.9)†
Marital status
Married/living with a partner 167 69.0) 12 (17.1) 155 (90.1)
Single/divorced 75 (31.0) 58 (82.9) 17 (9.9)
Working status
Employed 194 (81.2) 38 (55.1)† 156 (91.8)†
Student/unemployed 45 (18.8) 31 (44.9)† 14 (8.2)†
Perceived income adequacy
Insufficient/caution with expenses‡ 71 (29.6) 21 (30.0) 50 (29.4)†
Enough to make ends meet 127 (52.9) 32 (45.7) 95 (55.9)†
Comfortable 42 (17.5) 17 (24.3) 25 (14.7)†
Subjective social class
Low/middle-low 141 (71.6) 45 (72.6)† 96 (71.1)†
Middle-high/high 56 (28.4) 17 (27.4)† 39 (28.9)†
Preferred form of payment to gamete donors§
Fixed reward 45 (18.6)* 6 (8.6) 39 (22.7)
Compensation 87 (36.0)* 29 (41.4) 58 (33.7)
Reimbursement 104 (43.0)* 34 (48.6) 70 (40.7)
Purchase 6 (2.5)* 1 (1.4) 5 (2.9)
* Proportions do not add to 100% due to rounding
†The total does not add up to 70 donors and 172 recipients due to missing values (missings range from 1 to 8
among donors; and from 2 to 37 among recipients)
‡This category refers to the lowest perceived income adequacy
§ The categories presented refer to: fixed reward—a fixed amount of money that is the same for all oocyte and
sperm donors; compensation—a variable amount of money according to the type of gametes donated (oocytes/
sperm); reimbursement—a variable amount of money according to the donor’s actual expenses or losses resulting
from the donation; and purchase—a variable amount of money according to the characteristics of the donor
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[15], including Portugal [17]. Currently, oocyte and sperm do-
nors are reimbursed for time and expenses in over than one-third
of countries (e.g. Argentina, Australia, Belgium and China),
while 16 countries provide compensation beyond reimbursement
(e.g. Chile, Nigeria, Slovenia and Spain) [15, 16]. Thus, our
results highlight the need to reassess current policy toward the
implementation of a model of variable recompense that goes
beyond mere reimbursement to also include compensation for
discomfort and health complications, which tend to be experi-
enced more frequently by female donors.
The emphasis on ensuring solidarity-based motivations re-
vealed how the donation of gametes is mainly considered a sol-
idaristic practice throughwhich people arewilling to accept some
type of cost (a burden or loss resulting from the donation) to
assist others with whom they have something relevant in com-
mon [31], such as the importance of reaching parenthood [4].
This positioning may be rooted in a prevailing value of the
Catholicism, which is the predominant religion in Portugal, re-
lated with promoting solidarity among the members of a society
[31]. As previously reported in studies focused on the reasons
underlying acceptability of any kind of payment to gamete
donors, the mentioning of solidarity and altruism as reasons to
donate is not incompatible with the need to guarantee that do-
nors’ costs related with the donation are covered (e.g. travelling
and days off work). This is also seen as a fair option by donors in
studies in the UK [20] and Australia [6], as well as by recipients
in Belgium [21]. In line with the results of our study, the com-
pensation for the physical and emotional discomfort and further
health complications were also previously highlighted [20, 24].
The reimbursement of direct financial expenses and compensa-
tion for non-financial costs are thus compatible with the expres-
sion of an altruistic attitude [11, 28].
In addition to ensuring solidarity, the promotion of gender
equity emerged as a key concern for those who considered
compensation, varying for oocyte and sperm donors, as the
preferred form of payment to gamete donors. This view sup-
ported the recognition that a fair distribution of resources
should privilege women over men because oocyte donation
entails more discomfort, health risks and physical intrusion
than sperm donation [32, 33], instead of arguments of equal-
ity, which defend that individuals should be treated the same
as those with different attributes.
Table 2 Opinion about the preferred form of payment to gamete donors, according to the sociodemographic characteristics of the participants, stratified
by donors and recipients
Donors Recipients
Preferred form of payment
to gamete donors*
Fixed reward Compensation Reimbursement p Fixed reward Compensation Reimbursement p
n = 6 n = 29 n = 34 n = 39 n = 58 n = 70
Age, median (P25-P75) 31.5 (28.5–37.0) 27.0 (24.0–29.5) 25.0 (23.0–29.0) 0.016 36.0 (33.0–39.0) 36.0 (33.0–38.3) 36.0 (34.0–39.0) 0.805
n (%) n (%)
Sex
Female 4 (66.7) 18 (62.1) 23 (67.6) 0.929‡ 25 (64.1) 33 (56.9) 45 (64.3) 0.649
Male 2 (33.3) 11 (37.9) 11 (32.4) 14 (35.9) 25 (43.1) 25 (35.7)
Educational level
≤ Secondary education (12th grade) 4 (66.7) 13 (44.8) 14 (41.2) 0.515‡ 27 (73.0)† 31 (54.4)† 36 (52.9)† 0.116
> Secondary education (12th grade) 2 (33.3) 16 (55.2) 20 (58.8) 10 (27.0)† 26 (45.6)† 32 (47.1)†
Marital status
Married/living with a partner 1 (16.7) 4 (13.8) 7 (20.6) 0.801‡ 31 (79.5) 55 (94.8) 65 (92.9) 0.043‡
Single/divorced 5 (83.3) 25 (86.2) 27 (79.4) 8 (20.5) 3 (5.2) 5 (7.1)
Working status
Employed 6 (100.0) 14 (48.3) 18 (54.5) 0.061‡ 30 (81.1)† 57 (98.3) 64 (91.4) 0.012‡
Student/unemployed 0 15 (51.7) 15 (45.5) 7 (18.9)† 1 (1.7) 6 (8.6)
Perceived income adequacy
Insufficient/caution with expenses§ 1 (16.7) 13 (44.8) 7 (20.6) 0.131‡ 14 (37.8)**,† 15 (25.9)** 19 (27.1) 0.560
Enough to make ends meet 2 (33.3) 12 (41.4) 18 (52.9) 18 (48.6)**,† 36 (62.1)** 38 (54.3)
Comfortable 3 (50.0) 4 (13.8) 9 (26.5) 5 (13.5)**,† 7 (12.1)** 13 (18.6)
Subjective social class
Low/middle-low 5 (83.3) 18 (66.7)† 22 (75.9)† 0.643‡ 24 (75.0)† 32 (71.1)† 37 (69.8)† 0.855
Middle-high/high 1 (16.7) 9 (33.3)† 7 (24.1)† 8 (25.0)† 13 (28.9)† 16 (30.2)†
* The categories presented refer to: fixed reward—a fixed amount of money that is the same for all oocyte and sperm donors; compensation—a variable
amount of money according to the type of gametes donated (oocytes/sperm); and reimbursement—a variable amount of money according to the donor’s
actual expenses or losses resulting from the donation
** Proportions do not add to 100% due to rounding
†Due to missing values, the totals do not add up to 29 (compensation) and 34 (reimbursement) among donors, and to 39 (fixed reward), 58
(compensation) and 70 (reimbursement) among recipients (there are 7 missing cases among donors; and missings range from 2 to 37 among recipients)
‡ Fisher’s exact test
§ This category refers to the lowest perceived income adequacy
J Assist Reprod Genet
The few participants supporting a fixed reward never men-
tioned gender equity. Both donors and recipients reliedmostly on
arguments related to an equality of the value of sperm and eggs.
This ‘equal value’ attributed to gametes, often connected with a
comparison to the donation of other material (e.g. blood), may be
grounded in the significance attributed to the donation itself,
which is mostly focused on the result—i.e. the possibility of
generating a child—than in the donation process [21]. The pref-
erence for a fixed reward was most present among older donors.
Married/living with a partner or employed recipients seemed to
be less supportive of a fixed reward for gamete donors. This may
relate to the fact that older donors may be in a more stable
economic position and, thus, are not as sensitive to the need for
compensation or reimbursement of effective expenses.
Data was collected during a full year in the only
Public Bank of Gametes in Portugal, which is a positive
aspect accounting for the generalizability of the profile of
both donors and recipients. However, some limitations
should be acknowledged. First, although the recruitment
of the sample at the only Public Bank of Gametes has
allowed for the analyses of users of the public health care
system, differences in the positioning of participants may
be found among users of private centres. Thus, it would
be important to include them in future studies. Second,
the sample size is small, but it is comparable with most
studies investigating psychosocial attitudes, motivations
and experiences of oocyte donors, recipients and egg
sharers [34]; also, it should be framed in a context where
anonymity of gamete donors prevailed, which turns do-
nors and recipients of donated gametes into hard-to-
survey participants [35]. Additionally, this sample is
skewed by the level of education (more than 45% of
the respondents hold a university degree, while in
Portugal this percentage was of 22.9% in 2011) [36],
which could have affected the options of their preferred
forms of payment. Lastly, it would be interesting to also
collect information on participants’ views about the
amount of money that should be considered.
In summary, this study’s results allowed us to gather
relevant data that may contribute to inform policies re-
garding payment to gamete donors. It shows that donors’
and recipients’ views about the preferred form of payment
are influenced by a socioethical framework linked to
values of solidarity, gender equity or equality. This study
reinforces the need to promote a critical discussion around
the creation of payment solutions that can be adapted to
combine normative ethics with the perspectives and
values of those involved in gamete donation [3, 28].
However, more empirical studies are needed to provide
an in-depth understanding of the views of donors and
recipients on payment to gamete donors in the context
of the search for cross-border reproductive care and gam-
ete circulation across countries [14, 37]. The development
of international recommendations regarding ‘reasonable
compensation’ [11] could attenuate differences between
countries, by establishing maximum amounts that consid-
er gender equity and providing clear guidance on the ad-
justment to donor’s actual expenses and further health
complications.
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Ensuring solidarity-based motivations 3 6 26 6 8 33
Gender equity 0 24 2 0 30 14
Equality 5 0 2 17 0 4
Encouraging more people to become donors 0 1 3 4 8 7
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The total number of reasons (n = 224) is higher than the total number of respondents (n = 187), because 37 participants reported two reasons to sustain
their opinion
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